Viral Shah, MD, an endocrinologist and scientist, discusses ongoing research on preventing bone fractures in people with type 1 diabetes (T1D).
After discussing his own research on type 1 diabetes (T1D) and bone fracture risk, Viral Shah, MD, an endocrinologist and scientist, talks about the "resurgence in this interest" in T1D and osteoporosis research.
Transcript
What are some other exciting areas of research being pursued in the area of T1D and osteoporosis?
The diabetes and osteoporosis field is now becoming a hot topic. The reason is that we have a lot of tools to manage type 1 diabetes and type 2 diabetes. There are so many newer medications [and] diabetes technologies to deliver the insulin automatically. With all these advances, now people are living longer, and when people are living longer, particularly with type 1 or type 2 diabetes, they are also suffering from other comorbid conditions like cardiovascular disease, cognitive issues, and osteoporosis. I think it's a resurgence in this interest in this field to understand how diabetes is affecting the osteoporosis.
There are many people working in this area. Particularly what I'm doing in this area is that I'm focusing only on type 1 diabetes, not on type 2, because it's a totally different ballgame. But in type 1 diabetes, one of my studies funded by the NIH [National Institutes of Health] is trying to look at the bone tissue compositions and the material properties and how it is different in people with type 1 diabetes compared to people without diabetes. So [we're] trying to understand how diabetes would have influenced the tissue material properties of the bone.
And then another study that I have, again funded by the NIH, we are prospectively following patients with type 1 diabetes and without diabetes and looking at the change in the bone structural properties by doing a hip CT scan. And trying to look at what kind of factors would predict that kind of a change in the bone structure property. If we know what is changing that, then probably we can make some kind of therapeutic decisions or studies in the future to prevent that. So I'm hoping that some of these studies will provide really interesting findings and a next roadmap on preventing osteoporotic fractures in people with type 1 diabetes.
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
2 Commerce Drive
Cranbury, NJ 08512